Monday, January 12, 2009
FDA may miss researchers' financial conflicts
WASHINGTON - Missing information, loopholes and weak oversight hamper efforts to uncover financial conflicts by researchers who test experimental drugs before companies seek government approval, an internal watchdog finds....More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment